Deborah Stocken - Researcher Profile

Publications

2 shown

Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer

David Cunningham , Ian Chau , Deborah Stocken +17 more

Purpose Both gemcitabine (GEM) and fluoropyrimidines are valuable treatment for advanced pancreatic cancer. This open-label study was designed to compare the overall survival (O...

2009 Journal of Clinical Oncology 814 citations

Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study

John Primrose , Richard Fox , Daniel H. Palmer +84 more

2019 The Lancet Oncology 1136 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 3
Citations: 3,086
Institution: Cancer Research UK

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-8031-1738

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.